Get Articles Daily from StraightStocks - Enter Email Address


  • National Debt Clock


This Medical/dental-services company is flying below traders radars

Posted on Monday, June 30th, 2008 | In Stocks to Watch
Contributed by: Joshua Hayes (http://www.bigwavetrading.net) -

GXDX provides diagnostic services to community based oncologists and hematologist treating blood, bone marrow and other cancers. This business has been amazing for this company as the fundamentals have many mutual funds wanting to load up on this stock. That is why we have seen ownership grow from 27 funds last quarter to 42 funds in the most recent quarter.

This sort of accumulation with a management owning 46% of the shares outstanding is a severe confirmation of future price gains.

GXDSX has had some incredible recent quarterly EPS growth of 200%, 388%, 540%, 999% and 325% the past five quarters. On top of that current growth we have EPS estimates for 2008 and 2009 for YOY growth of 18% and 4% respectively.

Along with the incredible earings, the sales growth are doubly impressive with growth o f417%, 340%, 264%, 166%, 165%, 134%, 137%, and 109% the past eight quarters. This kind of sales growth with earnings growth will continue to find buyers on every pullback. I am also sure by the end of the year that mutual fund ownership will be over 100 funds.

For those that are interested in the P/E ratio, you can rest assured that the 29 P/E ratio is in the middle end of the 18-42 5-year range. With those kind of earnings, sales, ROE, and cash flow, the P/E could be 100 and I would still be a buyer of this stock.

IBD confirms the strength, with the EPS coming in with a n 80 rating, the Relative Strength rating of 91, a group RS rating of 70, a Sales+Margins+ROE rating of A, and Acc/Dis rating of B, a composite rating of B, and a mutual fund sponsorship rating of a D.

This is by far one of the best IPO’s out there in the medical community and a buy right here off the 50 day moving average gives us an excellent entry to an excellent stock that is sure to make investors with a long-term investment horizon a lot of money.

At the time of publication, Joshua did not have a position in Genoptix Inc. (GXDX)

Last 5 posts by Joshua Hayes





About Joshua Hayes (http://www.bigwavetrading.net)
Joshua "MauiTrader" Hayes is CEO, president and founder of Big Wave Trading Inc., a Maui, Hawaii-based stock market advisory service. Hayes is a well-respected stock picker and technician who combines fundamentals, psychology and money management to trade professionally in his own family, and friends accounts for more than 12 years on Maui. Hayes also runs BigWaveTrading.com, an online stock market commentary and stock selection service for short- and intermediate-term investment strategies using CANSLIM and other strategies. Hayes has been a contributor to Telechart as Sir Aloha, Realmoney.com, InvestorsParadise.com and TokyoJoe.com.

Leave a Reply

Name

Email (kept private)

Website









No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.